Manufacturing Brighter Futures, Together.

Ori is empowering scientists with flexible tools that streamline development and help to enable widespread patient access to life-saving cell and gene therapies. 

Explore IRO

Enabling Widespread Patient Access to Life-Saving Cell and Gene Therapies.

The Status Quo Isn’t Good Enough For Patients or the Industry

Manufacturing remains the critical barrier to scaling cell and gene therapies, directly impacting patient outcomes and company return on investment. Today’s CGTs are challenging to manufacture, impossible to make widely available, and not commercially viable due to the high cost of manufacturing, low throughput, and low reproducibility.

We must address these challenges as an industry to ensure the viability of cell therapies.

Manufacturing Brighter Futures

Ori is the leader in cell and gene therapy manufacturing technology that enables seamless transition from R&D into the clinic and to commercial scale manufacturing.

"The status quo in cell and gene therapy for most patients today represent death or serious disability"

Tim Hunt, CEO

Alliance for Regenerative Medicine (ARM)

Globally, fewer than 5% of patients who could benefit from approved therapies have been able to access them.

View Access Data

Combining Biology, Engineering, and Digital.

To enable widespread patient access to lifesaving cell and gene therapies, you need both superior biological performance and the benefits of digitally enabled automation to maximize your clinical and commercial impact.

Explore IRO® View Ori Data

Begin With Biology

Ori has taken a biology-first approach understanding that cell quality, potency, and yield are critical to successful patient outcomes.

Enable With Engineering

By automating manual steps and deskilling processes, Ori enables high throughput, high quality, and lower-cost manufacturing essential to reach scale and maximize both clinical and commercial impact.

Deliver With Digital

The cloud-native Ori platform helps to accelerate process development, reduce batch failures, and streamline batch release, resulting in shorter development times and more efficient manufacturing.